Dudediligence.

Azitra, Inc

AZTRAMEX · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

60.6M

on 2026-06-30, from 5.60M on 2025-09-30 10-Q ↗

Counts before 2025-09-30 are left out: the count went from 18.0M on 2025-06-30 to 5.60M on 2025-09-30, a change no split on file explains.

a raise that quarter, at its price

Newest

S-3 of 2024-07-01. Not read yet. S-3 ↗

$3.5M

A.G.P./Alliance Global Partners, agreement of 2026-09-28. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-12 is not read yet.

Cash

2.4 quarters

$6.7M on 2026-06-30 ÷ $2.8M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-03-18Private placement incl. 85.23M pre-funded85,243,611not read$10.5M8-K ↗
2025-11-24Private placement incl. 4.15M pre-funded4,687,500not read$1.5M8-K ↗
2025-02-04Registered direct offering3,339,300$0.2785$930K424B5 ↗
2025-01-14Public offering4,857,780$0.30$1.5M424B5 ↗